Loading company…
Beijing-based Quanto Bio develops diagnostic products for oncology and infectious diseases, including tuberculosis tests.
Founded in 2009 in Beijing, China, Quanto Bio specializes in diagnostic products for oncology and infectious diseases, including flow diagnostic systems, tumor screening series, tuberculosis products and molecular diagnostics. Its customers are hospitals, laboratories and research institutions, often through bulk order contracts. The company raised CNY 20.000 mn in a Series C round in January 2016 from Shenzhen Yuankang Investment Management. It reported 2019 revenue of CNY 15,353,056.30.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in